Screener
Inspire Medical Systems INSP Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001609550-26-000023
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $98,932 | $104,813 |
| Investments, short-term | 184,902 | 203,455 |
| Accounts receivable, net of allowance for credit losses of $1,266 and $1,080, respectively | 105,088 | 119,692 |
| Inventories, net | 166,235 | 145,293 |
| Prepaid expenses and other current assets | 11,662 | 10,399 |
Item 1. Financial Statements.
FAQ
- What is Inspire Medical Systems's cash & equivalents?
- Inspire Medical Systems (INSP) reported cash & equivalents of $98.93M in Q1 2026.
- How has Inspire Medical Systems's cash & equivalents changed year-over-year?
- Inspire Medical Systems's cash & equivalents increased by 83.6% year-over-year, from $53.88M to $98.93M.
- What is the long-term trend for Inspire Medical Systems's cash & equivalents?
- Over 5 years (2020 to 2025), Inspire Medical Systems's cash & equivalents has grown at a -11.3% compound annual growth rate (CAGR), from $190.52M to $104.81M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Inspire Medical Systems's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude